HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isabelle Meaux Selected Research

SAR405838

1/2022Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.
1/2018Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain Barrier.
3/2016SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.
10/2014SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isabelle Meaux Research Topics

Disease

3Neoplasms (Cancer)
01/2018 - 10/2014
2Liposarcoma
01/2022 - 03/2016
1Glioblastoma (Glioblastoma Multiforme)
01/2018
1Genomic Instability
03/2016
1Sarcoma (Soft Tissue Sarcoma)
03/2016
1Prostatic Neoplasms (Prostate Cancer)
10/2014
1Leukemia
10/2014
1Osteosarcoma (Osteogenic Sarcoma)
10/2014
1Colonic Neoplasms (Colon Cancer)
10/2014

Drug/Important Bio-Agent (IBA)

4SAR405838IBA
01/2022 - 10/2014
1GadoliniumIBA
01/2018
1Proteins (Proteins, Gene)FDA Link
10/2014
1Oncogene Proteins (Oncogene Protein)IBA
10/2014